What therapeutic targets can be derived from understanding FTD pathogenic mechanisms?

OPEN

The abstract explicitly states no effective treatment exists despite advances in understanding pathological classifications and genetic causes. This represents a critical translational gap from mechanistic knowledge to therapeutic intervention. Gap type: open_question Source paper: [Frontotemporal dementia: clinical features, genetics, pathogenesis and treatment]. (2013, Harefuah, PMID:24416825)

Priority: 0.74 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What therapeutic targets can be derived from understanding FTD pathogenic mechanisms? is a 0.74 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What therapeutic targets can be derived from understanding FTD pathogenic mechanisms? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (2)

ALSFTDLC3FTD

associated with (23)

PARKINSON'S DISEASEFTDALZHEIMER'S DISEASEFTDTARDBPFTDALSFTDTAUFTD
▸ Show 18 more

biomarker for (2)

Tau 3R/4R RatioFTDCryptic Hdgfl2FTD

causes (7)

ALSFTDTARDBPFTDTDP-43FTDC9ORF72FTDC9ORF72 REPEAT RNAFTD
▸ Show 2 more

contributes to (2)

Rbp DysfunctionFTDstress_granule_formationFTD

cross disease mechanism in (5)

TARDBPFTDC9ORF72FTDMAPTFTDTIA1FTDTBK1FTD

implicated in (1)

G3BP1FTD

interacts with (3)

ALSFTDFTDLRRK2FTDNEURONS

regulates (1)

ALSFTD

risk factor for (4)

C9orf72 expansionsFTDGgggcc Repeat ExpansionFTDC9orf72 HREFTDTBK1FTD
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps